It is the leading reason for liver transplants.
Food and Drug Administration.
Typically, only 15 percent to 20 percent of patients who get interferon are rid of all signs of the virus.
A combination of two virus-fighting drugs has proved considerably more effective against chronic hepatitis C infections than the standard single medicine.
In the United States nearly 4 million people are believed to have hepatitis C, with about 10,000 deaths from the disease each year.
, was approved in June only for patients who had relapsed after taking interferon drugs, the only other approved treatment for the disease.
A
